Xcout Intel
Flashpoint Therapeutics
Flashpoint Therapeutics is a clinical-stage biotechnology research company headquartered in Evanston, Illinois, developing a new class of precision-engineered structural nanomedicines through its proprietary platform.
Subscribe to see Flashpoint Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Flashpoint Therapeutics at a glance
Flashpoint Therapeutics is a biotechnology company headquartered in United States. Xcout tracks 8 named people at Flashpoint Therapeutics, including Barry Labinger (Chief Executive Officer).
Flashpoint Therapeutics leadership
- Barry LabingerChief Executive Officer
- Eric RowinskyConsulting Chief Medical Officer
- Venkat KrishnamurthyConsulting Chief Scientific Officer
- Chad MirkinScientific Founder Director, International Institute for Nanotechnology, Northwestern University
- Michelle Teplensky, PhDScientific Founder Assistant Professor of Chemical Engineering, Boston University
- Abdulrahman al Olayan, PhD, MBACEO & Managing Partner, Beta Lab
2 more named people on record for Flashpoint Therapeutics, with roles, board committees and tenure — see the full roster →
Flashpoint Therapeutics competitors
A few of Flashpoint Therapeutics's closest competitors — see the full list of competitors and alternatives →
Fulgent Pharma LLC is a clinical-stage pharmaceutical company that develops innovative cancer therapeutics using a patented nanoencapsulation technology. The company focuses on improving existing chemotherapy drugs and creating new drug candidates to treat various cancers while reducing toxicity and enhancing drug delivery and safety.
Matchpoint Therapeutics Inc. discovers and develops precision small molecule medicines utilizing covalent chemistry and chemoproteomics screening to treat immune diseases. The company leverages proprietary screening technologies and machine learning algorithms to expand the druggable proteome and design covalent drug candidates for patients with serious inflammatory and immune conditions.
BIND Therapeutics, Inc. is a clinical-stage nanomedicine company headquartered in Cambridge, Massachusetts. The company specializes in developing targeted and programmable therapeutics using its proprietary platform to treat various diseases.
Dewpoint Therapeutics is an integrated drug discovery platform company headquartered in Boston, Massachusetts. The firm leverages advanced biotechnology to translate condensate biology into novel medicines for various therapeutic areas.
Xanadu Bio, Inc. is a biotechnology company that develops next-generation polymer nanoparticle delivery platforms for mRNA and other nucleic acid-based therapies. Utilizing its proprietary poly(amine-co-ester) (PACE) polymer technology, the company creates tunable, organ-specific treatments for oncology and immunology, as well as intranasal vaccines for viral respiratory pathogens.
Phoreus Biotechnology, Inc. is a privately held biotechnology company founded in 2018 and headquartered in Olathe, Kansas. The company specializes in the development of proprietary nanocarriers for targeted drug delivery and enhanced treatments.
Get Flashpoint Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Flashpoint Therapeutics in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access